Live from the NIH registry
Studies recruiting near Ann Arbor right now
Top 25 of 1,171 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Pennsylvania
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
C.S. Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Nationwide Children's Hospital
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
University of Michigan Medical School — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
C S Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
University of Michigan ( Site 6000) — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Detroit Clinical Research Center — Farmington Hills, Michigan (23.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Kura Oncology, Inc.
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Motts Childrens Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study of the TheraBionic P1 Device in Breast Cancer
Breast Cancer Stage I, Breast Cancer Stage II
N/A
Interventional 24 participants sought
Karmanos Cancer Institute Weisberg Cancer Treatment Center — Farmington Hills, Michigan (23.1 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Trinity Health Ann Arbor Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: American Society of Clinical Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Trinity Health Saint Joseph Mercy Hospital Ann Arbor — Ann Arbor, Michigan (0.5 mi)
· Sponsor: SWOG Cancer Research Network
A Retrospective Study to Characterize Participants With Propionic Acidemia
Propionic Acidemia
N/A
Observational 60 participants sought
University of Michigan Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: ModernaTX, Inc.
Adversity, Brain and Opioid Use Study
Opioid Use Disorder, Healthy
N/A
Interventional 185 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Tr1X, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Ann Arbor, Michigan (0.5 mi)
· Sponsor: AstraZeneca
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Allen Park — Allen Park, Michigan (26.6 mi)
· Sponsor: Tectonic Operating Company, Inc.
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Dravet Syndrome
Phase 1, Phase 2
Interventional 32 participants sought
University of Michigan Health System — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
Treatment of the Biceps With Concomitant Supraspinatus Tears
Supraspinatus Tear
N/A
Interventional 180 participants sought
Sports Medicine and Shoulder Surgery, University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: La Tour Hospital
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — Ann Arbor, Michigan (0.5 mi)
· Sponsor: AstraZeneca
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Ann Arbor, Michigan (0.5 mi)
· Sponsor: AstraZeneca
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
Inflammatory Bowel Diseases
N/A
Interventional 40 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
C.S. Mott Children's Hospital - Cardiology — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Bayer
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Quest Research Institute — Farmington Hills, Michigan (23.1 mi)
· Sponsor: Annovis Bio Inc.
Access Sheath and Stent Trial
Kidney Stone, Ureteral Stone
N/A
Interventional 184 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan